Drug intelligence / Profile preview

FlexiQule MAX

Development stage
Unknown
Lead developer
Alchem International
Modality
Small Molecules
Administration
Topical
01

Overview

FlexiQule MAX is a topical botanical emollient developed by AlchemLife (a division of Alchem International) for the management of joint and muscle pain, stiffness, and inflammation. The formulation features a synergistic blend of phytoactive extracts, primarily Ginger (*Zingiber Officinale*) and *Boswellia Serrata* (Indian Frankincense), which are known to inhibit pro-inflammatory enzymes such as arachidonate 5-lipoxygenase (5-LOX) and prostaglandin-endoperoxide synthase (COX). It also contains Piperine to enhance the bioavailability of the active components, along with other botanical oils including *Celastrus Paniculata*, Lavender, Apricot, and Sunflower oils. Designed for topical application, FlexiQule MAX targets inflammation at the source and helps mitigate cartilage degeneration. While marketed for conditions like arthritis and backaches, it is classified as a natural wellness product or dietary supplement rather than an FDA-approved pharmaceutical.

Brand names
FlexiQule MAX
02

Targets

COXMMP12 (Macrophage Metalloelastase)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on FlexiQule MAX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FlexiQule MAX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call